Real-Time News FIRE FAST SIP Calculators

Easy-to-understand Financial Insights
that build Wealth.

Explore Dzambhala NodeX

DIVISLAB

NSE: DIVISLAB | BSE: 532488

Latest on DIVISLAB

Divi's Laboratories Reports Q1 FY2026 Earnings With ₹2,529 Cr Income and ₹545 Cr Profit After Tax August 12, 2025 | 9:31 a.m. IST
Divi's Laboratories Approves ₹30 Dividend and Reports ₹9,712 Cr Income in 35th AGM August 11, 2025 | 5:35 p.m. IST
Divi's Laboratories Declares ₹30 Dividend and Reports ₹2,191 Cr PAT at 35th AGM August 11, 2025 | 5:23 p.m. IST
Divi's Laboratories Reports Q1 FY2025-26 Earnings With ₹2,529 Cr Income and ₹545 Cr PAT August 6, 2025 | 12:04 p.m. IST
Divi's Laboratories Submits Business Responsibility and Sustainability Report for FY 2024-25, Emphasising Commitment to Responsible Practices July 14, 2025 | 7:26 p.m. IST
Divi's Laboratories Proposes ₹30 Dividend and Schedules 35th AGM for August 11, 2025 July 14, 2025 | 6:42 p.m. IST
Divi's Laboratories Schedules 35th AGM for August 11, Recommends ₹230 Dividend for FY 2024-25 July 11, 2025 | 1:11 p.m. IST
Divi's Laboratories VP G. Hemanth Kumar Set to Retire on April 30, 2025, Raising Concerns Over Production Operations April 30, 2025 | 10:41 a.m. IST
Divi's Laboratories Signs Long-Term Manufacturing Pact, Plans ₹650-700 Cr Investment for Capacity Expansion April 18, 2025 | 7:52 a.m. IST
Divi's Laboratories Confirms Retirement of General Manager G. Bala Kishore Effective March 31, 2025 March 31, 2025 | 9:22 a.m. IST
Divi's Laboratories Reappoints Dr. Kiran S. Divi as CEO with 88.48% Approval in Postal Ballot March 7, 2025 | 1:13 p.m. IST
Divi's Laboratories Shareholders Approve Re-appointment of Dr. Kiran S. Divi as CEO for Five More Years March 7, 2025 | 12:52 p.m. IST
Divi's Laboratories Reports Q3 FY2025 Standalone Profit Surge to ₹594 Cr, Total Income Rises to ₹2,379 Cr February 3, 2025 | 2:09 p.m. IST
Divi's Laboratories Reports Q3 FY25 Income of ₹2401 Cr and PAT of ₹589 Cr, Driven by Strong Growth February 3, 2025 | 1:19 p.m. IST
Divi's Laboratories Reports Q3 FY25 Income of ₹2401 Cr and PAT of ₹589 Cr, Up 64% Year-on-Year February 3, 2025 | 1:17 p.m. IST
Divi's Laboratories Reports Q3 FY25 Income Surge to ₹2401 Cr and PAT Rise to ₹589 Cr February 3, 2025 | 1:05 p.m. IST
Divi's Laboratories To Announce Q3FY25 Earnings On February 3, 2025, With Conference Call Scheduled January 28, 2025 | 2:49 p.m. IST
Divi's Laboratories To Approve Q3 Financial Results On February 3, 2025; Insider Trading Window Closed January 23, 2025 | 12:52 p.m. IST